Unveiling wild-type transthyretin cardiac amyloidosis as a significant and potentially modifiable cause of heart failure with preserved ejection fraction.
Publication/Presentation Date
10-7-2015
Volume
36
Issue
38
First Page
2595
Last Page
2597
ISSN
1522-9645
Published In/Presented At
Castaño, Adam et al. “Unveiling wild-type transthyretin cardiac amyloidosis as a significant and potentially modifiable cause of heart failure with preserved ejection fraction.” European heart journal vol. 36,38 (2015): 2595-7. doi:10.1093/eurheartj/ehv328
Disciplines
Medicine and Health Sciences
PubMedID
26224073
Department(s)
Department of Medicine
Document Type
Article
COinS